Carcione Dale, Regan Annette K, Tracey Lauren, Mak Donna B, Gibbs Robyn, Dowse Gary K, Bulsara Max, Effler Paul V
Communicable Disease Control Directorate, Department of Health, Perth, WA, Australia.
Communicable Disease Control Directorate, Department of Health, Perth, WA, Australia; School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.
Vaccine. 2015 Oct 13;33(42):5654-5661. doi: 10.1016/j.vaccine.2015.08.066. Epub 2015 Aug 29.
During a pertussis epidemic in 2011-2012 the Western Australian (WA) Department of Health implemented a 'cocooning' programme, offering free pertussis-containing vaccine (dTpa) to new parents. We assessed the impact of vaccinating parents with dTpa on the incidence of pertussis infection in newborns. Births in WA during 2011-2012 were linked to a register of parental pertussis vaccinations and to notified reports of laboratory-proven pertussis in children <6 months of age. Parents who received dTpa during the four weeks after their child's birth were defined as 'vaccinated postpartum.' Cox proportional-hazards methods were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of pertussis infection among infants born to parents vaccinated postpartum vs. unvaccinated parents, adjusted for maternal age, geographic region, timing of birth, and number of siblings. Of 64,364 live-births, 43,480 (68%) infants had at least one vaccinated parent (60% of mothers and 36% of fathers). After excluding records where parent(s) were either vaccinated prior to the birth, vaccinated >28 days after the birth, the vaccination date was uncertain, or the child died at birth (n=42), the final cohort contained 53,149 children, 118 of whom developed pertussis. There was no difference in the incidence of pertussis among infants whose parents were both vaccinated postpartum compared to those with unvaccinated parents (1.9 vs 2.2 infections per 1000 infants; adjusted HR 0.91; 95%CI 0.55-1.53). Similarly, when assessed independently, maternal postpartum vaccination was not protective (adjusted HR 1.19; 95%CI 0.82-1.72). Supplemental sensitivity analyses which varied the time period for parental vaccination and accounted for under-reporting of vaccination status did not significantly alter these findings. In our setting, vaccinating parents with dTpa during the four weeks following delivery did not reduce pertussis diagnoses in infants. WA now provides dTpa vaccine to pregnant women during the third trimester.
在2011 - 2012年百日咳疫情期间,西澳大利亚州(WA)卫生部实施了一项“围产期免疫”计划,为新生儿父母提供免费的含百日咳疫苗(白百破疫苗)。我们评估了为父母接种白百破疫苗对新生儿百日咳感染发病率的影响。2011 - 2012年西澳大利亚州的出生记录与父母百日咳疫苗接种登记册以及6个月以下儿童经实验室确诊的百日咳报告相关联。在孩子出生后四周内接种白百破疫苗的父母被定义为“产后接种疫苗者”。采用Cox比例风险法计算产后接种疫苗的父母所生婴儿与未接种疫苗的父母所生婴儿相比患百日咳感染风险的风险比(HRs)和95%置信区间(CIs),并对产妇年龄、地理区域、出生时间和兄弟姐妹数量进行了调整。在64364例活产中,43480例(68%)婴儿至少有一位接种疫苗的父母(60%的母亲和36%的父亲)。在排除父母在孩子出生前接种疫苗、出生后超过28天接种疫苗、疫苗接种日期不确定或孩子出生时死亡的记录(n = 42)后,最终队列包含53149名儿童,其中118名患百日咳。与父母未接种疫苗的婴儿相比,父母均在产后接种疫苗的婴儿百日咳发病率没有差异(每1000名婴儿中分别为1.9例和2.2例感染;调整后的HR为0.91;95%CI为0.55 - 1.53)。同样,单独评估时,产妇产后接种疫苗并无保护作用(调整后的HR为1.19;95%CI为0.82 - 1.72)。改变父母接种疫苗的时间段并考虑疫苗接种状态报告不足的补充敏感性分析并未显著改变这些结果。在我们的研究环境中,在分娩后四周内为父母接种白百破疫苗并不能减少婴儿百日咳的诊断病例。西澳大利亚州现在在孕晚期为孕妇提供白百破疫苗。